Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2008-9-19
pubmed:databankReference
pubmed:abstractText
We report the X-ray structures of several bisphosphonate inhibitors of geranylgeranyl diphosphate synthase, a target for anticancer drugs. Bisphosphonates containing unbranched side chains bind to either the farnesyl diphosphate (FPP) substrate site, the geranylgeranyl diphosphate (GGPP) product site, and in one case, both sites, with the bisphosphonate moiety interacting with 3 Mg (2+) that occupy the same position as found in FPP synthase. However, each of three "V-shaped" bisphosphonates bind to both the FPP and GGPP sites. Using the Glide program, we reproduced the binding modes of 10 bisphosphonates with an rms error of 1.3 A. Activities of the bisphosphonates in GGPPS inhibition were predicted with an overall error of 2x by using a comparative molecular similarity analysis based on a docked-structure alignment. These results show that some GGPPS inhibitors can occupy both substrate and product site and that binding modes as well as activity can be accurately predicted, facilitating the further development of GGPPS inhibitors as anticancer agents.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-10026212, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-10222271, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-10512752, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-11465420, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-12014956, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-12142347, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-14561085, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-14613320, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-14672944, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-15828834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-15958534, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16288456, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16517172, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16539721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16554305, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16578835, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16684881, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16698791, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16774691, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-16892359, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-17034125, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-17062572, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-17208200, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-17535895, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-17963374, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-7990113, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-8086404, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-8177887, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-8294948, http://linkedlifedata.com/resource/pubmed/commentcorrection/18800762-9757107
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1520-4804
pubmed:author
pubmed:issnType
Electronic
pubmed:day
25
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5594-607
pubmed:dateRevised
2010-9-22
pubmed:meshHeading
pubmed:year
2008
More...